MEGHAN COGSWELL: Open Payments
NPI 1427287002 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,147 in 78 payments from 16 companies in 2025. Trend: 2023 $3,074 · 2024 $3,121 · 2025 $2,147
Food & beverage: $2,147
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $570 |
| PFIZER INC. | 14 | $346 |
| EMD Serono, Inc. | 8 | $346 |
| Novartis Pharmaceuticals Corporation | 15 | $195 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| UCB, Inc. | 1 | $123 |
| Lundbeck LLC | 2 | $98 |
| Neurelis, Inc. | 2 | $73 |
| Amgen Inc. | 2 | $56 |
| TG Therapeutics, Inc. | 2 | $50 |
Products named: QULIPTA, Mavenclad, NURTEC ODT, KESIMPTA, BOTOX, PONVORY, Fintepla, ZAVZPRET.
Industry payments across CO — which companies pay providers there.
